A 59-year-old woman was referred to our hospital because of severe anemia and leucopenia. Although she developed mild arthralgia without the typical symptoms of systemic lupus erythematosus (SLE), positivity for anti-Sm antibodies led us to a diagnosis of late-onset SLE. Autoimmune hemolytic anemia (AIHA) and suppression of reticulocyte production were considered to have been involved in the etiology of severe anemia. Administration of oral prednisolone (PSL) resulted in a marked improvement of the hematological abnormalities. As late-onset SLE is rare and patients tend to show the typical symptoms less frequently, close attention should be focused on latent symptoms and immunological findings.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease predominantly affecting young people and showing a well known female predilection [1, 2] . Age at onset has been recognized as having a modifying effect on the clinical manifestations of SLE, and thus late onset in persons aged 50 years and above may constitute a specific subgroup of SLE [3] [4] [5] . Patients with late-onset SLE seem to show a more insidious disease onset, and are less likely to have major organ involvement [1] . This may give rise to a delay in diagnosis due to lack of typical clinical manifestations. Here, we report a case of late onset-SLE associated with severe anemia.
CASE REPORT
A 59-year-old woman was admitted to our hospital with severe anemia and leukopenia. Upon admission she complained of arthralgia in her ankles and felt fatigue and dyspnea on exertion. Vital signs on presentation included blood pressure 134/62 mmHg, pulse rate 92 per min with a regular rhythm, body temperature 36.0℃, and respiration rate 22 per min. The palpebral conjunctivae were anemic without bulbar jaundice. On chest auscultation, the heart and breath sounds were clear. The abdomen was soft and flat, and the spleen was not palpable. Neurological status was normal. Peripheral lymphadenopathy and edema were not noted. However, the right ankle was swollen and painful. No skin rash was evident on the face or extremities.
Laboratory evaluation (Table 1) revealed normochromic normocytic anemia (Hb: 5.7 g/dl), leucopenia (2000/μl), thrombocytopenia (11.1×10
4 /μl) and reticulocytopenia (2.2‰). Blood coagulation tests gave normal results. The serum protein level was high at 8.56 g/dl, and indirect hyperbilirubinemia was detected. The serum level of erythropoietin was high (2440 mIU/ml). Renal function tests and urinalysis gave normal results, and the CRP level was not elevated. Immunological tests showed that the patient was positive for anti-nuclear antibodies (ANA) with a titer of 1:160 (nucleolar and cytoplasmic pattern). Anti-DNA antibodies were not detected and C3 and C4 were normal. Anti-Sm antibodies, anti-U1 RNP antibodies, anti-SS-A antibodies and rheumatoid factor were positive. Anti-cardiolipin antibodies and lupus anticoagulant were negative. Serological studies showed no evidence of recent infection with Epstein-Barr virus or Parvovirus B19.
Bone marrow aspiration revealed normoplastic marrow without trilineage dysplasia (nucleic cell count; 9.6×10 4 /μl). Myeloid/Erythroid ratio was 3-4:1, suggesting the presence of mild erythroid hypoplasia. No increase in the number of blast cells was observed. Moreover, hemophagocytosis was not detected in the bone marrow. The presence of anti-Sm antibodies, specific antibodies for SLE, and normal bone marrow findings suggested that autoimmunity might be involved in the peripheral hematopenia. Positivity in the direct Coombs test, substantial reduction of haptoglobin (<10 normal: 25-176 mg/dl) and indirect hyperbilirubinemia suggested autoimmune hemolytic anemia (AIHA) as a complication. The patient was diagnosed as having SLE on the basis of the 1997 American College of Rheumatology revised criteria for classification of SLE, in view of the presence of arthritis, AIHA, leucopenia, positive anti-Sm antibodies and an abnormal titer in ANA. The patient was treated with oral prednisolone (PSL) 50 mg/day, equivalent to 1 mg/day/kg body weight. As shown in Fig. 1 , initiation of PSL resulted in an evident improvement of the anemia, leucopenia and reticulocytopenia. Reduction of the PSL dose was possible, and the patient was dis-26 charged from hospital in an improved condition. The serum haptoglobin level became normalized during the subsequent outpatient course.
DISCUSSION
SLE is an autoimmune disease that predominantly affects women under 50 years of age and involves multiple organ systems, mainly the kidneys, cardiovascular system, skin, and central nervous system. In a national survey of 1614 SLE patients in Japan, onset in persons aged 50 and above was rare at 6.4% [6] . Generally, the onset is insidious, and the interval between onset and diagnosis is longer than in younger patients [7, 8] . Although prior studies have suggested that late onset-SLE is associated with a benign clinical course and better prognosis than SLE in younger patients [1, 9] , some authors have considered that the degree of organ damage is greater in late onset-SLE [10, 11] . Although our present patient had mild erythroid hypoplasia, severe anemia was evident, with a minimum Hb level of 3.9 mg/dl (Fig. 1) . Thus, early diagnosis and treatment is clearly necessary for patients with late onset-SLE.
In late onset-SLE patients, serositis (pericarditis, pleuritis), interstitial pulmonary disease and Sjögren's syndrome are more prevalent, whereas lupus nephritis, neuropsychiatric illness and skin manifestations are uncommon [1, 7] . Furthermore, Raynaud's phenomenon, alopecia and lymphadenopathy are present less frequently in elderly patients [1, 12] . Arthritis, arthralgia and findings resembling polymyalgia rheumatica are initial manifestations of late onset-SLE [13] . Consistent with these features, the present patient had arthritis in her left ankle and lacked typical symptoms such as skin manifestations. Cytopenias are found more commonly in late onset-SLE, and were present as a complication in this patient [14] . Although it has been reported that anti-ds DNA antibodies and anti-Sm antibodies are present less frequently in late onset-SLE patients [1, 9] , some authors have demonstrated a higher prevalence of anti-Sm antibodies in both younger and elderly patients [7] . Anti-Sm antibodies were detected in the present case, and this led us to the diagnosis of SLE. Diagnosis of SLE in elderly individuals is difficult because of the lack of typical physical and laboratory features that are usually present in younger patients. Therefore, careful attention needs to be paid to latent symptoms and immunological laboratory findings.
Although it was initially suspected that anemia in SLE was mainly a result of antibody-induced erythrocyte damage, evidence to date indicates that its causes can vary and that the pathogenesis may be immune or non-immune [15] . In the present case, bone marrow examination excluded various syndromes of hemopoi- etic failure, such as aplastic anemia, myeloid line hypoplasia, and pure red cell aplasia. Indirect hyperbilirubinemia, substantial reduction of the serum haptoglobin level, and positivity in the direct Coombs test suggested AIHA as a complication. Although no elevation of the reticulocyte count was evident in the peripheral blood, pathogenic T cells in SLE patients may mediate suppression of erythroid production and abrogate any reactive elevation of the reticulocyte count in AIHA [16] . In this patient, AIHA and inhibition of reticulocyte production were considered to have been involved in the etiology of the severe anemia. Furthermore, the numbers of reticulocytes and the levels of hemoglobin and haptoglobin recovered after the start of steroid therapy, and thus autoimmunity-induced damage to blood cells may have occurred.
In conclusion, although SLE occurs rarely in patients of advanced age, discrimination of late onset-SLE in the elderly is important in Japan, in view of the increase in the proportion of aged individuals in the population. Careful attention to physical and immunological features is required in order to avoid any delay in diagnosis.
